AstraZeneca PLC (LSE:AZN)
£ 106.12 0.8 (0.76%) Market Cap: 164.52 Bil Enterprise Value: 185.50 Bil PE Ratio: 32.60 PB Ratio: 5.34 GF Score: 89/100

AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session Transcript

Mar 25, 2021 / 02:30PM GMT
Release Date Price: £72.1 (+1.12%)
Nick Stone
AstraZeneca PLC - IR

Hello. Welcome, ladies and gentlemen, to today's Meet Astrazeneca Management Biopharmaceutical event. I'm Nick Stone, your moderator for today and a member of the Astrazeneca IR team. I'd like to welcome you to this opening session with Ruud Dobber, Executive Vice President of Biopharmaceuticals Business Unit; and Mene Pangalos, Executive Vice President of Biopharmaceuticals R&D. We also have several members of the Biopharmaceutical management team available as well.

This opening session will last for around 45 minutes. There'll be a short presentation, followed by Q&A. We will aim to finish around 3:15 to provide some time ahead of the first breakout session, which will start at 3:30. We'll then run a further breakout at 4:15, aiming to finish around 5:00. I hope you like the virtual setup and the potential to interact with Ruud and many members of the team.

As usual, the presentation materials are available on astrazeneca.com/investors, and we would encourage you to look here for all of the latest details. We've also sent the details and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot